通过吸入器标签改进喘自我管理教育
Lea C Dikranian1, D Elizabeth Irish2, Kathleen E Shanley3
1Children's Hospital of Michigan, Detroit, MI, United States of America.
PEC innovation
|September 10, 2024
概括
喘吸入器上的彩色编码标签,区分救援和维护药物,药剂师成功实施了. 这种低成本的工具有助于患者正确使用药物,并改善喘自我管理.
科学领域:
- 药房实践的做法 在药房实践.
- 患者教育 患者教育
- 喘管理的管理
背景情况:
- 缺乏对喘药物的了解和使用导致喘失控和住院治疗.
- 药剂师是通过自我管理教育改善喘药物治疗的关键.
- 颜色编码标签对吸入器差异化的有效性以前没有被探索过.
研究的目的:
- 评估社区药房中喘吸入器颜色编码标签的可行性和实用性.
- 评估这项干预措施对喘自我管理教育的影响.
主要方法:
- 社区药房加入了喘联盟并接受了培训.
- 药剂师使用彩色编码的贴纸:红色用于救援吸入器 (短效β-2激动剂) 和绿色用于控制器吸入器 (吸入皮质类固醇或ICS/长效β-2激动剂组合).
主要成果:
- 25家药房参与了两年时间,标签了超过6000个救援和9000个控制器吸入器.
- 该计划为1000多名儿童和7000多名成年人提供服务.
- 药房成功地使用了彩色编码的标签.
结论:
- 彩色编码的喘药物标签是药房的实用和有效工具.
- 这种低成本的创新提高了患者的理解,并促进了适当的喘药物使用,改善了自我管理.
相关概念视频
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Inhaled Medications
241
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
241
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
COPD: Management Using Bronchodilators and Corticosteroids
188
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
188


